Feedback (FDBK) Competitors GBX 20.50 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines FDBK vs. INHC, IQAI, DVRG, TRLS, SENS, EMIS, CRW, INS, KOO, and RENXShould you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry. Feedback vs. Induction Healthcare Group IQ-AI DeepVerge Trellus Health Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Induction Healthcare Group (LON:INHC) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation. Is INHC or FDBK more profitable? Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -279.16%. Induction Healthcare Group's return on equity of -14.53% beat Feedback's return on equity.Company Net Margins Return on Equity Return on Assets Induction Healthcare Group-23.86% -14.53% -7.32% Feedback -279.16%-35.63%-22.99% Does the MarketBeat Community believe in INHC or FDBK? Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote. CompanyUnderperformOutperformInduction Healthcare GroupOutperform Votes1493.33% Underperform Votes16.67%FeedbackOutperform Votes16567.07% Underperform Votes8132.93% Do insiders and institutionals believe in INHC or FDBK? 46.3% of Induction Healthcare Group shares are owned by institutional investors. Comparatively, 53.2% of Feedback shares are owned by institutional investors. 54.6% of Induction Healthcare Group shares are owned by insiders. Comparatively, 10.8% of Feedback shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has higher valuation & earnings, INHC or FDBK? Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInduction Healthcare Group£13.65M0.62-£3.25M-£0.03-300.00Feedback£1.18M2.32-£3.30M-£0.25-82.00 Does the media prefer INHC or FDBK? In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score. Company Overall Sentiment Induction Healthcare Group Neutral Feedback Neutral Which has more volatility & risk, INHC or FDBK? Induction Healthcare Group has a beta of -0.41, suggesting that its stock price is 141% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. SummaryInduction Healthcare Group beats Feedback on 8 of the 13 factors compared between the two stocks. Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Get Feedback News Delivered to You Automatically Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FDBK vs. The Competition Export to ExcelMetricFeedbackHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£2.73M£197.25M£5.11B£1.45BDividend Yield4.56%6.51%5.05%11.41%P/E Ratio-82.00697.70108.891,587.66Price / Sales2.32344.871,233.22225,724.00Price / Cash1.1244.9039.9334.26Price / Book0.365.316.942.86Net Income-£3.30M-£7.48M£119.18M£136.51M7 Day Performance0.75%-0.58%-1.36%-0.55%1 Month Performance-60.80%1.97%-3.27%3.42%1 Year Performance-71.54%1.10%32.40%100.47% Feedback Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FDBKFeedbackN/AGBX 20.50flatN/A-72.7%£2.73M£1.18M-82.0024INHCInduction Healthcare GroupN/AGBX 9flatN/AN/A£8.45M£13.65M-316.6774IQAIIQ-AIN/AGBX 1.40+7.7%N/A-65.7%£3.10M£538,190.00-13.676News CoverageDVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073TRLSTrellus HealthN/AGBX 0.67-4.3%N/A-85.3%£1.08M£35,000.00-23.3331SENSSensyne HealthN/AN/AN/A+0.0%£583,000.00£7.81M-0.0270Gap DownEMISEMIS GroupN/AGBX 1,920flatN/A+0.0%£1.23B£176.86M4,085.111,560CRWCraneware1.8423 of 5 starsGBX 2,220+0.5%GBX 2,700+21.6%+37.3%£784.55M£189.27M8,525.00734High Trading VolumeINSInstemN/AGBX 830flatN/A+0.0%£199.62M£61.63M5,928.57500KOOKooth1.9513 of 5 starsGBX 163-1.2%GBX 585+258.9%-45.0%£59.46M£54.17M1,358.33478RENXRenalytixN/AGBX 7.50-3.2%N/A-68.1%£12.45M£2.29M-30.00102News CoverageGap Down Related Companies and Tools Related Companies INHC Alternatives IQAI Alternatives DVRG Alternatives TRLS Alternatives SENS Alternatives EMIS Alternatives CRW Alternatives INS Alternatives KOO Alternatives RENX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:FDBK) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Feedback plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Feedback With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
